ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

FHTX Foghorn Therapeutics Inc

5,98
0,35 (6,22%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:30:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Foghorn Therapeutics Inc FHTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,35 6,22% 5,98 22:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,51 5,51 5,97 5,98 5,63
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202422:54EDGAR2Form 8-K - Current report
06.5.202413:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202413:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
06.5.202413:03EDGAR2Form 8-K - Current report
07.3.202413:11EDGAR2Form 8-K - Current report
07.3.202413:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08.2.202413:04EDGAR2Form 8-K - Current report
25.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:09EDGAR2Form 8-K - Current report
08.1.202413:04EDGAR2Form 8-K - Current report
03.1.202422:18EDGAR2Form 8-K - Current report
28.11.202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21.11.202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02.11.202312:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202312:03EDGAR2Form 8-K - Current report
01.11.202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11.9.202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08.9.202313:04EDGAR2Form 8-K - Current report
05.9.202314:00GLOBEFoghorn Therapeutics Announces Participation in Upcoming..
31.8.202313:04EDGAR2Form 8-K - Current report
31.8.202313:00GLOBEFoghorn Therapeutics Announces First Patient Dosed in Phase..
29.8.202315:00PRNUSInvaio achieves first registration for citrus greening..
18.8.202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.8.202322:08EDGAR2Form 8-K - Current report
08.8.202313:05EDGAR2Form 8-K - Current report
08.8.202313:00GLOBEFoghorn Therapeutics Announces Chief Medical Officer..
04.8.202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04.8.202313:05EDGAR2Form 8-K - Current report
04.8.202313:00GLOBEFoghorn Therapeutics Provides Second Quarter 2023 Financial..
28.6.202313:00GLOBEFoghorn Therapeutics Announces Clinical Data from Phase 1..
05.6.202314:07DJNFoghorn Therapeutics Shares Rally Premarket as FDA Lifts..
16.5.202312:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock